APO Research
Talk to an analyst

APO RESEARCH · REPORT

Efavirenz

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Efavirenz Market Analysis and Forecast 2026-2032

22 December 2025199 pages

Choose your research edition.

Industry ResearchEfavirenz Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Efavirenz Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Efavirenz Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Efavirenz Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Efavirenz Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Efavirenz market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Efavirenz is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Efavirenz is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Efavirenz is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Efavirenz is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Efavirenz include Teva, Mylan, Macleods Pharmaceuticals, Hetero, Cipla, Bristol-Myers Squibb and Aurobindo Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Efavirenz, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Efavirenz, also provides the sales of main regions and countries. Of the upcoming market potential for Efavirenz, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Efavirenz sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Efavirenz market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Efavirenz sales, projected growth trends, production technology, application and end-user industry.

Efavirenz Segment by Company

Teva

Mylan

Macleods Pharmaceuticals

Hetero

Cipla

Bristol-Myers Squibb

Aurobindo Pharma

Efavirenz Segment by Type

Two-drug combination

Three-drug combination

Efavirenz Segment by Application

Adults

Children

Efavirenz Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Efavirenz market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Efavirenz and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Efavirenz.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Efavirenz in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Efavirenz manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Efavirenz sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Efavirenz Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Two-drug combination Major Manufacturers Table 3. Three-drug combination Major Manufacturers Table 4. Global Efavirenz Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Adults Major Manufacturers Table 6. Children Major Manufacturers Table 7. Efavirenz Industry Trends Table 8. Efavirenz Industry Drivers Table 9. Efavirenz Industry Opportunities and Challenges Table 10. Efavirenz Industry Restraints Table 11. Global Efavirenz Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 12. Global Efavirenz Revenue by Region (2021-2026) & (US$ Million) Table 13. Global Efavirenz Revenue by Region (2027-2032) & (US$ Million) Table 14. Global Efavirenz Revenue Market Share by Region (2021-2026) Table 15. Global Efavirenz Revenue Market Share by Region (2027-2032) Table 16. Global Efavirenz Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 17. Global Efavirenz Sales by Region (2021-2026) & (k units) Table 18. Global Efavirenz Sales by Region (2027-2032) & (k units) Table 19. Global Efavirenz Sales Market Share by Region (2021-2026) Table 20. Global Efavirenz Sales Market Share by Region (2027-2032) Table 21. Global Efavirenz Revenue by Manufacturers (US$ Million) & (2021-2026) Table 22. Global Efavirenz Revenue Market Share by Manufacturers (2021-2026) Table 23. Global Efavirenz Sales by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Efavirenz Sales Market Share by Manufacturers (2021-2026) Table 25. Global Efavirenz Sales Price (US$/unit) of Manufacturers (2021-2026) Table 26. Global Efavirenz Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 27. Global Efavirenz Key Manufacturers Manufacturing Sites & Headquarters Table 28. Global Efavirenz Manufacturers, Product Type & Application Table 29. Global Efavirenz Manufacturers' Establishment Date Table 30. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 31. Global Efavirenz by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 32. Global Efavirenz Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Efavirenz Revenue by Type (2021-2026) & (US$ Million) Table 34. Global Efavirenz Revenue by Type (2027-2032) & (US$ Million) Table 35. Global Efavirenz Revenue Market Share by Type (2021-2026) Table 36. Global Efavirenz Revenue Market Share by Type (2027-2032) Table 37. Global Efavirenz Sales by Type 2021 VS 2025 VS 2032 (k units) Table 38. Global Efavirenz Sales by Type (2021-2026) & (k units) Table 39. Global Efavirenz Sales by Type (2027-2032) & (k units) Table 40. Global Efavirenz Sales Market Share by Type (2021-2026) Table 41. Global Efavirenz Sales Market Share by Type (2027-2032) Table 42. Global Efavirenz Price by Type (2021-2026) & (US$/unit) Table 43. Global Efavirenz Price by Type (2027-2032) & (US$/unit) Table 44. Global Efavirenz Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 45. Global Efavirenz Revenue by Application (2021-2026) & (US$ Million) Table 46. Global Efavirenz Revenue by Application (2027-2032) & (US$ Million) Table 47. Global Efavirenz Revenue Market Share by Application (2021-2026) Table 48. Global Efavirenz Revenue Market Share by Application (2027-2032) Table 49. Global Efavirenz Sales by Application 2021 VS 2025 VS 2032 (k units) Table 50. Global Efavirenz Sales by Application (2021-2026) & (k units) Table 51. Global Efavirenz Sales by Application (2027-2032) & (k units) Table 52. Global Efavirenz Sales Market Share by Application (2021-2026) Table 53. Global Efavirenz Sales Market Share by Application (2027-2032) Table 54. Global Efavirenz Price by Application (2021-2026) & (US$/unit) Table 55. Global Efavirenz Price by Application (2027-2032) & (US$/unit) Table 56. Teva Company Information Table 57. Teva Business Overview Table 58. Teva Efavirenz Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 59. Teva Efavirenz Product Portfolio Table 60. Teva Recent Development Table 61. Mylan Company Information Table 62. Mylan Business Overview Table 63. Mylan Efavirenz Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 64. Mylan Efavirenz Product Portfolio Table 65. Mylan Recent Development Table 66. Macleods Pharmaceuticals Company Information Table 67. Macleods Pharmaceuticals Business Overview Table 68. Macleods Pharmaceuticals Efavirenz Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. Macleods Pharmaceuticals Efavirenz Product Portfolio Table 70. Macleods Pharmaceuticals Recent Development Table 71. Hetero Company Information Table 72. Hetero Business Overview Table 73. Hetero Efavirenz Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Hetero Efavirenz Product Portfolio Table 75. Hetero Recent Development Table 76. Cipla Company Information Table 77. Cipla Business Overview Table 78. Cipla Efavirenz Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Cipla Efavirenz Product Portfolio Table 80. Cipla Recent Development Table 81. Bristol-Myers Squibb Company Information Table 82. Bristol-Myers Squibb Business Overview Table 83. Bristol-Myers Squibb Efavirenz Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Bristol-Myers Squibb Efavirenz Product Portfolio Table 85. Bristol-Myers Squibb Recent Development Table 86. Aurobindo Pharma Company Information Table 87. Aurobindo Pharma Business Overview Table 88. Aurobindo Pharma Efavirenz Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Aurobindo Pharma Efavirenz Product Portfolio Table 90. Aurobindo Pharma Recent Development Table 91. North America Efavirenz Revenue by Type (2021-2026) & (US$ Million) Table 92. North America Efavirenz Revenue by Type (2027-2032) & (US$ Million) Table 93. North America Efavirenz Sales by Type (2021-2026) & (k units) Table 94. North America Efavirenz Sales by Type (2027-2032) & (k units) Table 95. North America Efavirenz Sales Price by Type (2021-2026) & (US$/unit) Table 96. North America Efavirenz Sales Price by Type (2027-2032) & (US$/unit) Table 97. North America Efavirenz Revenue by Application (2021-2026) & (US$ Million) Table 98. North America Efavirenz Revenue by Application (2027-2032) & (US$ Million) Table 99. North America Efavirenz Sales by Application (2021-2026) & (k units) Table 100. North America Efavirenz Sales by Application (2027-2032) & (k units) Table 101. North America Efavirenz Sales Price by Application (2021-2026) & (US$/unit) Table 102. North America Efavirenz Sales Price by Application (2027-2032) & (US$/unit) Table 103. North America Efavirenz Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 104. North America Efavirenz Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 105. North America Efavirenz Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 106. North America Efavirenz Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 107. North America Efavirenz Sales by Country (2021-2026) & (k units) Table 108. North America Efavirenz Sales by Country (2027-2032) & (k units) Table 109. North America Efavirenz Sales Price by Country (2021-2026) & (US$/unit) Table 110. North America Efavirenz Sales Price by Country (2027-2032) & (US$/unit) Table 111. United States Efavirenz Revenue (2021-2032) & (US$ Million) Table 112. Canada Efavirenz Revenue (2021-2032) & (US$ Million) Table 113. Mexico Efavirenz Revenue (2021-2032) & (US$ Million) Table 114. Europe Efavirenz Revenue by Type (2021-2026) & (US$ Million) Table 115. Europe Efavirenz Revenue by Type (2027-2032) & (US$ Million) Table 116. Europe Efavirenz Sales by Type (2021-2026) & (k units) Table 117. Europe Efavirenz Sales by Type (2027-2032) & (k units) Table 118. Europe Efavirenz Sales Price by Type (2021-2026) & (US$/unit) Table 119. Europe Efavirenz Sales Price by Type (2027-2032) & (US$/unit) Table 120. Europe Efavirenz Revenue by Application (2021-2026) & (US$ Million) Table 121. Europe Efavirenz Revenue by Application (2027-2032) & (US$ Million) Table 122. Europe Efavirenz Sales by Application (2021-2026) & (k units) Table 123. Europe Efavirenz Sales by Application (2027-2032) & (k units) Table 124. Europe Efavirenz Sales Price by Application (2021-2026) & (US$/unit) Table 125. Europe Efavirenz Sales Price by Application (2027-2032) & (US$/unit) Table 126. Europe Efavirenz Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. Europe Efavirenz Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 128. Europe Efavirenz Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 129. Europe Efavirenz Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 130. Europe Efavirenz Sales by Country (2021-2026) & (k units) Table 131. Europe Efavirenz Sales by Country (2027-2032) & (k units) Table 132. Europe Efavirenz Sales Price by Country (2021-2026) & (US$/unit) Table 133. Europe Efavirenz Sales Price by Country (2027-2032) & (US$/unit) Table 134. Germany Efavirenz Revenue (2021-2032) & (US$ Million) Table 135. France Efavirenz Revenue (2021-2032) & (US$ Million) Table 136. U.K. Efavirenz Revenue (2021-2032) & (US$ Million) Table 137. Italy Efavirenz Revenue (2021-2032) & (US$ Million) Table 138. Russia Efavirenz Revenue (2021-2032) & (US$ Million) Table 139. Spain Efavirenz Revenue (2021-2032) & (US$ Million) Table 140. Netherlands Efavirenz Revenue (2021-2032) & (US$ Million) Table 141. Switzerland Efavirenz Revenue (2021-2032) & (US$ Million) Table 142. Sweden Efavirenz Revenue (2021-2032) & (US$ Million) Table 143. Poland Efavirenz Revenue (2021-2032) & (US$ Million) Table 144. China Efavirenz Revenue by Type (2021-2026) & (US$ Million) Table 145. China Efavirenz Revenue by Type (2027-2032) & (US$ Million) Table 146. China Efavirenz Sales by Type (2021-2026) & (k units) Table 147. China Efavirenz Sales by Type (2027-2032) & (k units) Table 148. China Efavirenz Sales Price by Type (2021-2026) & (US$/unit) Table 149. China Efavirenz Sales Price by Type (2027-2032) & (US$/unit) Table 150. China Efavirenz Revenue by Application (2021-2026) & (US$ Million) Table 151. China Efavirenz Revenue by Application (2027-2032) & (US$ Million) Table 152. China Efavirenz Sales by Application (2021-2026) & (k units) Table 153. China Efavirenz Sales by Application (2027-2032) & (k units) Table 154. China Efavirenz Sales Price by Application (2021-2026) & (US$/unit) Table 155. China Efavirenz Sales Price by Application (2027-2032) & (US$/unit) Table 156. Asia Efavirenz Revenue by Type (2021-2026) & (US$ Million) Table 157. Asia Efavirenz Revenue by Type (2027-2032) & (US$ Million) Table 158. Asia Efavirenz Sales by Type (2021-2026) & (k units) Table 159. Asia Efavirenz Sales by Type (2027-2032) & (k units) Table 160. Asia Efavirenz Sales Price by Type (2021-2026) & (US$/unit) Table 161. Asia Efavirenz Sales Price by Type (2027-2032) & (US$/unit) Table 162. Asia Efavirenz Revenue by Application (2021-2026) & (US$ Million) Table 163. Asia Efavirenz Revenue by Application (2027-2032) & (US$ Million) Table 164. Asia Efavirenz Sales by Application (2021-2026) & (k units) Table 165. Asia Efavirenz Sales by Application (2027-2032) & (k units) Table 166. Asia Efavirenz Sales Price by Application (2021-2026) & (US$/unit) Table 167. Asia Efavirenz Sales Price by Application (2027-2032) & (US$/unit) Table 168. Asia Efavirenz Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 169. Asia Efavirenz Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 170. Asia Efavirenz Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 171. Asia Efavirenz Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 172. Asia Efavirenz Sales by Country (2021-2026) & (k units) Table 173. Asia Efavirenz Sales by Country (2027-2032) & (k units) Table 174. Asia Efavirenz Sales Price by Country (2021-2026) & (US$/unit) Table 175. Asia Efavirenz Sales Price by Country (2027-2032) & (US$/unit) Table 176. Japan Efavirenz Revenue (2021-2032) & (US$ Million) Table 177. South Korea Efavirenz Revenue (2021-2032) & (US$ Million) Table 178. India Efavirenz Revenue (2021-2032) & (US$ Million) Table 179. Australia Efavirenz Revenue (2021-2032) & (US$ Million) Table 180. Taiwan Efavirenz Revenue (2021-2032) & (US$ Million) Table 181. Southeast Asia Efavirenz Revenue (2021-2032) & (US$ Million) Table 182. SAMEA Efavirenz Revenue by Type (2021-2026) & (US$ Million) Table 183. SAMEA Efavirenz Revenue by Type (2027-2032) & (US$ Million) Table 184. SAMEA Efavirenz Sales by Type (2021-2026) & (k units) Table 185. SAMEA Efavirenz Sales by Type (2027-2032) & (k units) Table 186. SAMEA Efavirenz Sales Price by Type (2021-2026) & (US$/unit) Table 187. SAMEA Efavirenz Sales Price by Type (2027-2032) & (US$/unit) Table 188. SAMEA Efavirenz Revenue by Application (2021-2026) & (US$ Million) Table 189. SAMEA Efavirenz Revenue by Application (2027-2032) & (US$ Million) Table 190. SAMEA Efavirenz Sales by Application (2021-2026) & (k units) Table 191. SAMEA Efavirenz Sales by Application (2027-2032) & (k units) Table 192. SAMEA Efavirenz Sales Price by Application (2021-2026) & (US$/unit) Table 193. SAMEA Efavirenz Sales Price by Application (2027-2032) & (US$/unit) Table 194. SAMEA Efavirenz Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 195. SAMEA Efavirenz Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 196. SAMEA Efavirenz Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 197. SAMEA Efavirenz Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 198. SAMEA Efavirenz Sales by Country (2021-2026) & (k units) Table 199. SAMEA Efavirenz Sales by Country (2027-2032) & (k units) Table 200. SAMEA Efavirenz Sales Price by Country (2021-2026) & (US$/unit) Table 201. SAMEA Efavirenz Sales Price by Country (2027-2032) & (US$/unit) Table 202. Brazil Efavirenz Revenue (2021-2032) & (US$ Million) Table 203. Argentina Efavirenz Revenue (2021-2032) & (US$ Million) Table 204. Chile Efavirenz Revenue (2021-2032) & (US$ Million) Table 205. Colombia Efavirenz Revenue (2021-2032) & (US$ Million) Table 206. Peru Efavirenz Revenue (2021-2032) & (US$ Million) Table 207. Saudi Arabia Efavirenz Revenue (2021-2032) & (US$ Million) Table 208. Israel Efavirenz Revenue (2021-2032) & (US$ Million) Table 209. UAE Efavirenz Revenue (2021-2032) & (US$ Million) Table 210. Turkey Efavirenz Revenue (2021-2032) & (US$ Million) Table 211. Iran Efavirenz Revenue (2021-2032) & (US$ Million) Table 212. Egypt Efavirenz Revenue (2021-2032) & (US$ Million) Table 213. Key Raw Materials Table 214. Raw Materials Key Suppliers Table 215. Efavirenz Distributors List Table 216. Efavirenz Customers List Table 217. Research Programs/Design for This Report Table 218. Authors List of This Report Table 219. Secondary Sources Table 220. Primary Sources List of Figures Figure 1. Efavirenz Image Figure 2. Global Efavirenz Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Efavirenz Market Size Share 2021 VS 2025 VS 2032 Figure 4. Two-drug combination Image Figure 5. Three-drug combination Image Figure 6. Global Efavirenz Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Efavirenz Market Size Share 2021 VS 2025 VS 2032 Figure 8. Adults Image Figure 9. Children Image Figure 10. Global Efavirenz Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Efavirenz Revenue (2021-2032) & (US$ Million) Figure 12. Global Efavirenz Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 13. Global Efavirenz Revenue Market Share by Region: 2025 Versus 2032 Figure 14. Global Efavirenz Revenue Market Share by Region (2021-2032) Figure 15. Global Efavirenz Sales (2021-2032) & (k units) Figure 16. Global Efavirenz Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 17. Global Efavirenz Sales Market Share by Region (2021-2032) Figure 18. US & Canada & Mexico Efavirenz Sales YoY (2021-2032) & (k units) Figure 19. Europe Efavirenz Sales YoY (2021-2032) & (k units) Figure 20. China Efavirenz Sales YoY (2021-2032) & (k units) Figure 21. Asia (Excluding China) Efavirenz Sales YoY (2021-2032) & (k units) Figure 22. South America, Middle East and Africa Efavirenz Sales YoY (2021-2032) & (k units) Figure 23. Global Efavirenz Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 24. Global Efavirenz Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 25. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 26. Global Efavirenz Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Efavirenz Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 28. Global Efavirenz Revenue Market Share by Type (2021-2032) Figure 29. Global Efavirenz Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 30. Global Efavirenz Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Efavirenz Sales Market Share by Type (2021-2032) Figure 32. Global Efavirenz Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Efavirenz Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 34. Global Efavirenz Revenue Market Share by Application (2021-2032) Figure 35. Global Efavirenz Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 36. Global Efavirenz Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Efavirenz Sales Market Share by Application (2021-2032) Figure 38. North America Efavirenz Revenue Share by Type (2021-2032) Figure 39. North America Efavirenz Sales Share by Type (2021-2032) Figure 40. North America Efavirenz Revenue Share by Application (2021-2032) Figure 41. North America Efavirenz Sales Share by Application (2021-2032) Figure 42. North America Efavirenz Revenue Share by Country (2021-2032) Figure 43. North America Efavirenz Sales Share by Country (2021-2032) Figure 44. Europe Efavirenz Revenue Share by Type (2021-2032) Figure 45. Europe Efavirenz Sales Share by Type (2021-2032) Figure 46. Europe Efavirenz Revenue Share by Application (2021-2032) Figure 47. Europe Efavirenz Sales Share by Application (2021-2032) Figure 48. Europe Efavirenz Revenue Share by Country (2021-2032) Figure 49. Europe Efavirenz Sales Share by Country (2021-2032) Figure 50. China Efavirenz Revenue Share by Type (2021-2032) Figure 51. China Efavirenz Sales Share by Type (2021-2032) Figure 52. China Efavirenz Revenue Share by Application (2021-2032) Figure 53. China Efavirenz Sales Share by Application (2021-2032) Figure 54. Asia Efavirenz Revenue Share by Type (2021-2032) Figure 55. Asia Efavirenz Sales Share by Type (2021-2032) Figure 56. Asia Efavirenz Revenue Share by Application (2021-2032) Figure 57. Asia Efavirenz Sales Share by Application (2021-2032) Figure 58. Asia Efavirenz Revenue Share by Country (2021-2032) Figure 59. Asia Efavirenz Sales Share by Country (2021-2032) Figure 60. SAMEA Efavirenz Revenue Share by Type (2021-2032) Figure 61. SAMEA Efavirenz Sales Share by Type (2021-2032) Figure 62. SAMEA Efavirenz Revenue Share by Application (2021-2032) Figure 63. SAMEA Efavirenz Sales Share by Application (2021-2032) Figure 64. SAMEA Efavirenz Revenue Share by Country (2021-2032) Figure 65. SAMEA Efavirenz Sales Share by Country (2021-2032) Figure 66. Efavirenz Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Efavirenz Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Two-drug combination
  • Three-drug combination
Applications
  • Adults
  • Children
Companies covered
  • Teva
  • Mylan
  • Macleods Pharmaceuticals
  • Hetero
  • Cipla
  • Bristol-Myers Squibb
  • Aurobindo Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Efavirenz Market by Type
  3. 1.2.1 Global Efavirenz Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Two-drug combination
  5. 1.2.3 Three-drug combination
  6. 1.3 Efavirenz Market by Application
  7. 1.3.1 Global Efavirenz Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Adults
  9. 1.3.3 Children
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Efavirenz Market Dynamics
  1. 2.1 Efavirenz Industry Trends
  2. 2.2 Efavirenz Industry Drivers
  3. 2.3 Efavirenz Industry Opportunities and Challenges
  4. 2.4 Efavirenz Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Efavirenz Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Efavirenz Revenue by Region
  3. 3.2.1 Global Efavirenz Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Efavirenz Revenue by Region (2021-2026)
  5. 3.2.3 Global Efavirenz Revenue by Region (2027-2032)
  6. 3.2.4 Global Efavirenz Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Efavirenz Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Efavirenz Sales by Region
  9. 3.4.1 Global Efavirenz Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Efavirenz Sales by Region (2021-2026)
  11. 3.4.3 Global Efavirenz Sales by Region (2027-2032)
  12. 3.4.4 Global Efavirenz Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Efavirenz Revenue by Manufacturers
  2. 4.1.1 Global Efavirenz Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Efavirenz Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Efavirenz Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Efavirenz Sales by Manufacturers
  6. 4.2.1 Global Efavirenz Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Efavirenz Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Efavirenz Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Efavirenz Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Efavirenz Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Efavirenz Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Efavirenz Manufacturers, Product Type & Application
  13. 4.7 Global Efavirenz Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Efavirenz Market CR5 and HHI
  16. 4.8.2 2025 Efavirenz Tier 1, Tier 2, and Tier 3
5 Efavirenz Market by Type
  1. 5.1 Global Efavirenz Revenue by Type
  2. 5.1.1 Global Efavirenz Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Efavirenz Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Efavirenz Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Efavirenz Sales by Type
  6. 5.2.1 Global Efavirenz Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Efavirenz Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Efavirenz Sales Market Share by Type (2021-2032)
  9. 5.3 Global Efavirenz Price by Type
6 Efavirenz Market by Application
  1. 6.1 Global Efavirenz Revenue by Application
  2. 6.1.1 Global Efavirenz Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Efavirenz Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Efavirenz Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Efavirenz Sales by Application
  6. 6.2.1 Global Efavirenz Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Efavirenz Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Efavirenz Sales Market Share by Application (2021-2032)
  9. 6.3 Global Efavirenz Price by Application
7 Company Profiles
  1. 7.1 Teva
  2. 7.1.1 Teva Company Information
  3. 7.1.2 Teva Business Overview
  4. 7.1.3 Teva Efavirenz Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Teva Efavirenz Product Portfolio
  6. 7.1.5 Teva Recent Developments
  7. 7.2 Mylan
  8. 7.2.1 Mylan Company Information
  9. 7.2.2 Mylan Business Overview
  10. 7.2.3 Mylan Efavirenz Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Mylan Efavirenz Product Portfolio
  12. 7.2.5 Mylan Recent Developments
  13. 7.3 Macleods Pharmaceuticals
  14. 7.3.1 Macleods Pharmaceuticals Company Information
  15. 7.3.2 Macleods Pharmaceuticals Business Overview
  16. 7.3.3 Macleods Pharmaceuticals Efavirenz Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Macleods Pharmaceuticals Efavirenz Product Portfolio
  18. 7.3.5 Macleods Pharmaceuticals Recent Developments
  19. 7.4 Hetero
  20. 7.4.1 Hetero Company Information
  21. 7.4.2 Hetero Business Overview
  22. 7.4.3 Hetero Efavirenz Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Hetero Efavirenz Product Portfolio
  24. 7.4.5 Hetero Recent Developments
  25. 7.5 Cipla
  26. 7.5.1 Cipla Company Information
  27. 7.5.2 Cipla Business Overview
  28. 7.5.3 Cipla Efavirenz Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Cipla Efavirenz Product Portfolio
  30. 7.5.5 Cipla Recent Developments
  31. 7.6 Bristol-Myers Squibb
  32. 7.6.1 Bristol-Myers Squibb Company Information
  33. 7.6.2 Bristol-Myers Squibb Business Overview
  34. 7.6.3 Bristol-Myers Squibb Efavirenz Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Bristol-Myers Squibb Efavirenz Product Portfolio
  36. 7.6.5 Bristol-Myers Squibb Recent Developments
  37. 7.7 Aurobindo Pharma
  38. 7.7.1 Aurobindo Pharma Company Information
  39. 7.7.2 Aurobindo Pharma Business Overview
  40. 7.7.3 Aurobindo Pharma Efavirenz Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Aurobindo Pharma Efavirenz Product Portfolio
  42. 7.7.5 Aurobindo Pharma Recent Developments
8 North America
  1. 8.1 North America Efavirenz Market Size by Type
  2. 8.1.1 North America Efavirenz Revenue by Type (2021-2032)
  3. 8.1.2 North America Efavirenz Sales by Type (2021-2032)
  4. 8.1.3 North America Efavirenz Price by Type (2021-2032)
  5. 8.2 North America Efavirenz Market Size by Application
  6. 8.2.1 North America Efavirenz Revenue by Application (2021-2032)
  7. 8.2.2 North America Efavirenz Sales by Application (2021-2032)
  8. 8.2.3 North America Efavirenz Price by Application (2021-2032)
  9. 8.3 North America Efavirenz Market Size by Country
  10. 8.3.1 North America Efavirenz Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Efavirenz Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Efavirenz Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Efavirenz Market Size by Type
  2. 9.1.1 Europe Efavirenz Revenue by Type (2021-2032)
  3. 9.1.2 Europe Efavirenz Sales by Type (2021-2032)
  4. 9.1.3 Europe Efavirenz Price by Type (2021-2032)
  5. 9.2 Europe Efavirenz Market Size by Application
  6. 9.2.1 Europe Efavirenz Revenue by Application (2021-2032)
  7. 9.2.2 Europe Efavirenz Sales by Application (2021-2032)
  8. 9.2.3 Europe Efavirenz Price by Application (2021-2032)
  9. 9.3 Europe Efavirenz Market Size by Country
  10. 9.3.1 Europe Efavirenz Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Efavirenz Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Efavirenz Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Efavirenz Market Size by Type
  2. 10.1.1 China Efavirenz Revenue by Type (2021-2032)
  3. 10.1.2 China Efavirenz Sales by Type (2021-2032)
  4. 10.1.3 China Efavirenz Price by Type (2021-2032)
  5. 10.2 China Efavirenz Market Size by Application
  6. 10.2.1 China Efavirenz Revenue by Application (2021-2032)
  7. 10.2.2 China Efavirenz Sales by Application (2021-2032)
  8. 10.2.3 China Efavirenz Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Efavirenz Market Size by Type
  2. 11.1.1 Asia Efavirenz Revenue by Type (2021-2032)
  3. 11.1.2 Asia Efavirenz Sales by Type (2021-2032)
  4. 11.1.3 Asia Efavirenz Price by Type (2021-2032)
  5. 11.2 Asia Efavirenz Market Size by Application
  6. 11.2.1 Asia Efavirenz Revenue by Application (2021-2032)
  7. 11.2.2 Asia Efavirenz Sales by Application (2021-2032)
  8. 11.2.3 Asia Efavirenz Price by Application (2021-2032)
  9. 11.3 Asia Efavirenz Market Size by Country
  10. 11.3.1 Asia Efavirenz Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Efavirenz Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Efavirenz Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Efavirenz Market Size by Type
  2. 12.1.1 SAMEA Efavirenz Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Efavirenz Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Efavirenz Price by Type (2021-2032)
  5. 12.2 SAMEA Efavirenz Market Size by Application
  6. 12.2.1 SAMEA Efavirenz Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Efavirenz Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Efavirenz Price by Application (2021-2032)
  9. 12.3 SAMEA Efavirenz Market Size by Country
  10. 12.3.1 SAMEA Efavirenz Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Efavirenz Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Efavirenz Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Efavirenz Value Chain Analysis
  2. 13.1.1 Efavirenz Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Efavirenz Production Mode & Process
  6. 13.2 Efavirenz Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Efavirenz Distributors
  9. 13.2.3 Efavirenz Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst